Clinical Trial Update: Dendritic Cells (DC) Vaccine for Metastatic Melanoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on a dendritic cell vaccine for metastatic melanoma; the study was terminated and results were posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Dendritic Cells Vaccine (dendritic cell vaccine)

Snippet

Sponsor: John Kirkwood | Conditions: Metastatic Melanoma | Phase 2 | Status: TERMINATED | Results posted: 2017-08-16